Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group

D. Pectasides; Gerasimos Aravantinos; Haralabos P. Kalofonos; Christos Kiamouris; D. Bafaloukos; Nikolaos I. Xiros; C. Nicolaides; A. Visvikis; Meletios A Dimopoulos

doi:10.1023/a:1012599307090

Article2003

Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group

D. Skarlos, Meletios A Dimopoulos, Paraskevas Kosmidis, Pavlos Papakostas, Nicholas Pavlidis, Charalambos Bacoyiannis, Christos Kiamouris, Georgios Klouvas, Helen Gogas, George Fountzilas, E. Samantas

Article2005

Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B‐cell lymphoma: a phase‐II trial by the Hellenic Cooperative Oncology Group

E. S. Papageorgiou, Panagiotis Tsirigotis, Meletios A Dimopoulos, Nikolaos Pavlidis, George Fountzilas, Sotirios G. Papageorgiou, Theofanis Economopoulos

Article1998

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group

George Fountzilas, Meletios A Dimopoulos, C. Papadimitriou, Anna Kalogera‐Fountzila, Gerasimos Aravantinos, Dimitrios Bafaloukos, A. Athanassiades, C. Nicolaides, Antonios Keramopoulos, Nicholas Pavlidis, P. Kosmidis, Dimosthenis Skarlos

Article2020

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial

Αngelos Koutras, Flora Zagouri, Georgia-Angeliki Koliou, Elizabeth Psoma, Ioannis Chryssogonidis, Georgios Lazaridis, Dimitrios Tryfonopoulos, Αthanasios Kotsakis, Eleni Res, Ν. Kentepozidis, Evangelia Razis, Amanda Psyrri, G. Koumakis, Haralabos P. Kalofonos, Meletios A Dimopoulos, George Fountzilas

Article2003

The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group

G.F. Samelis, Dimosthenis Skarlos, Dimitrios Bafaloukos, P. Kosmidis, Αchilles Anagnostopoulos, Gerasimos Aravantinos, Meletios A Dimopoulos

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group

Discussion(0)

Related publications

Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group

Combination chemotherapy with gemcitabine and vinorelbine in the treatment of relapsed or refractory diffuse large B‐cell lymphoma: a phase‐II trial by the Hellenic Cooperative Oncology Group

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes—a Hellenic Cooperative Oncology Group (HeCOG) Trial

The combination of estramustine and mitoxantrone in hormone-refractory prostate cancer: a phase II feasibility study conducted by the Hellenic Cooperative Oncology Group